Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience Meeting Abstract


Authors: O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; Neylon, E.; Zelenetz, A. D.; Saunders, M. E.; Mould, D. R.; Fleischer, M.; Sirotnak, F.; Horwitz, S. M.
Abstract Title: Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience
Meeting Title: 48th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 108
Issue: 11 Pt. 1
Meeting Dates: 2006 Dec 9-12
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2006-11-01
Start Page: 122A
End Page: 123A
Language: English
ACCESSION: WOS:000242440000401
PROVIDER: wos
PUBMED: 17139767
Notes: --- - Meeting Abstract: 400 - 48th Annual Meeting of the American-Society-of-Hematology - DEC 09-12, 2006 - Orlando, FL - Part 1 - "Source: Wos"
MSK Authors
  1. Carol Portlock
    181 Portlock
  2. Craig Moskowitz
    375 Moskowitz
  3. Ariela Noy
    208 Noy
  4. Steven M Horwitz
    364 Horwitz
  5. Chaya S. Moskowitz
    173 Moskowitz
  6. Andrew D Zelenetz
    556 Zelenetz
  7. Paul Hamlin
    174 Hamlin
  8. David J Straus
    213 Straus
  9. Francis M Sirotnak
    120 Sirotnak
  10. Ellen Neylon
    10 Neylon